When we launched vitiligo.ai back in 2023, the idea was simple: make reliable information about vitiligo available to anyone, anywhere, in any language. What could possibly go wrong, right?

Fast forward two years — turns out AI can sound smart, act caring, and still be utterly clueless. It imitates empathy but doesn’t actually care. It oozes confidence but often has no idea what it’s talking about.

In this episode, Yan Valle — professor, researcher, and the slightly obsessive nerd behind vitiligo.ai — shares what really happens when you try to teach a machine to teach medicine. The wins, the fails, and the very human mess in between.

You’ll hear:

• Why AI gets the facts right but the feelings wrong
• How “AI therapists” can cross lines no human ever should
• Why biased data quietly poisons good science
• And what dermatology looks like when algorithms start calling the shots

AI is brilliant at answering questions — just not always the right ones.

This episode is a reminder that intelligence is easy to fake. Humanity isn’t.

Here's the long read

This one’s long overdue — but too important to ignore.

On May 24, 2025, the World Health Organization finally looked up from its stack of pandemics and cholesterol charts and said, “Oh right — skin diseases exist.” They’re now officially a global public health priority.

Took only 2 billion people and a few decades of collective itching, burning, and patching to get there.

In this episode, we break down what this shiny new WHO resolution actually means — and what it absolutely doesn’t. Vitiligo didn’t make the guest list (unless you’re psoriasis, Buruli ulcer, or Mycetoma — congrats, I guess), but the door to real recognition just cracked open.

We’ll talk about:

• Why this resolution matters — even if it’s 90% PR and 10% progress
• How patient advocates quietly dragged skin health onto WHO’s radar
• What it’ll take to turn this bureaucratic “maybe” into something that actually helps people

It’s not the revolution — it’s the prelude.

But hey, after years of being ignored, even a polite nod from Geneva feels like a small win.

Here’s the original post

Vitiligo has always had a delivery problem. Creams can’t get past the skin’s outer “brick wall,” and systemic drugs hit the whole body.

Now, nanotechnology is changing that — turning microscopic carriers into smart delivery trucks that sneak medicine exactly where it’s needed.

In this episode:

• Why most creams fail to reach pigment cells
• How nano-formulations like liposomal khellin and ethosomal psoralens boost light therapy
• What’s coming next — topical JAK inhibitors, antioxidant particles, even gene-editing patches

Nanotech isn’t a cure, but it’s making current treatments sharper, safer, and more precise.

The future of vitiligo therapy might just fit on the head of a pin.

For more details, read Nanotechnology for Vitiligo in 2025 – Tiny Tools, Big Hopes